platoseedplatoseed
Medicinal Chemistry powered by Machine Learning
PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.
PostEra is a biopharma company that uses an AI platform called Proton to accelerate medicinal chemistry and drug discovery. They position themselves as a modern biopharma leveraging machine learning to speed up the discovery of new medicines for patients.
Proton is PostEra's AI platform for medicinal chemistry used to accelerate drug discovery. The company highlights partnerships and collaborations in AI-driven drug discovery with major biopharma players, leveraging Proton to address challenges in drug discovery and to advance medicines for patients.
Who it’s for: Pharmaceutical and biotech companies seeking AI-driven medicinal chemistry acceleration and collaboration on drug discovery programs.
Multiple high-profile collaborations and partnerships with Pfizer and Amgen, indicating significant industry traction and funding/partnership activity.
Menten AI designs peptide and protein therapeutics using quantum…
Combining 3D cell culture & AI to translate drugs to clinical success
